Literature DB >> 25639479

Iatrogenic pathology of the intestines.

Aoife J McCarthy1, Gregory Y Lauwers, Kieran Sheahan.   

Abstract

Many drugs and chemical agents can cause enteritis and colitis, producing clinical gastrointestinal side effects, the most common of which are diarrhoea, constipation, nausea and vomiting. Significant histological overlap exists between some patterns of medication or chemical injury and various disease entities. A particular medication may cause multiple patterns of injury and may mimic common entities such as coeliac disease, Crohn's disease, infectious enteritis and colitis. Thus, given the common absence of specific histopathological features, the diagnosis often relies upon thorough clinicopathological correlation. This review concentrates on selected examples of medication-induced injury of the intestinal tract in which the pathology can be recognized, particularly on biopsies, with a focus on newly described medication-induced gastrointestinal effects.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  colon; damage; drug-induced; gastrointestinal tract; iatrogenic; injury; large intestine; medication-induced; side effects; small intestine

Mesh:

Year:  2015        PMID: 25639479     DOI: 10.1111/his.12598

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  8 in total

Review 1.  Biopsy diagnosis of colitis: an algorithmic approach.

Authors:  Deepa T Patil; Robert D Odze
Journal:  Virchows Arch       Date:  2017-11-25       Impact factor: 4.064

2.  Mixed lymphocytic and collagenous inflammation of the entire gastrointestinal tract under therapy with serotonin and norepinephrine reuptake inhibitors.

Authors:  Ana I Varelas; Stefan Fürst; Cord Langner
Journal:  Virchows Arch       Date:  2022-06-02       Impact factor: 4.064

Review 3.  Gut inflammation induced by drugs: Can pathology help to differentiate from inflammatory bowel disease?

Authors:  Naoimh Herlihy; Roger Feakins
Journal:  United European Gastroenterol J       Date:  2022-05-28       Impact factor: 6.866

4.  Olmesartan-associated enteropathy.

Authors:  Vivian S Ebrahim; Jason Martin; Stacey Murthy; Elizabeth Odstrcil; He Huang; Daniel Polter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

5.  Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C.

Authors:  Ilaria Izzo; Paola Zanotti; Claudia Chirico; Salvatore Casari; Vincenzo Villanacci; Marianna Salemme; Luciano Biasi; Elena Festa; Francesco Castelli
Journal:  Infection       Date:  2016-06-16       Impact factor: 3.553

Review 6.  Ilececum: A Comprehensive Review.

Authors:  Shou-Jiang Tang; Ruonan Wu
Journal:  Can J Gastroenterol Hepatol       Date:  2019-02-03

Review 7.  Adverse Gastrointestinal Effects with Kayexalate or Kalimate: A Comprehensive Review.

Authors:  Yi-Hua Wu; Jen-Wei Chou; Hsiang-Chun Lai; Gin-Shen Su; Ken-Sheng Cheng; Tsung-Wei Chen
Journal:  Clin Exp Gastroenterol       Date:  2021-01-11

8.  Colitis Following Initiation of Sofosbuvir and Simeprevir for Genotype 1 Hepatitis C.

Authors:  Souvik Sarkar; Kisha A Mitchell; Joseph K Lim; Ioannis Oikonomou; Simona Jakab
Journal:  ACG Case Rep J       Date:  2015-10-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.